April 2021
Psilocybin vs. Escitalopram Phase II Trial Inconclusive
The trial was not designed to test whether psilocybin is equivalent to escitalopram.
Timeline of Psychedelic Drug Approvals
August 2020
Canada’s Health Minister Grants Section 56 Exemptions for Four Late-Stage Cancer Patients
Patty Hajdu approves exemption applications filed by patients who received support and assistance from non-profit organization TheraPsil.
December 2019
Silo Wellness Introduces First Magic Mushroom Nasal Spray
Nasal spray formulations like this could offer precision dosing of a spectrum of psychedelic mushroom compounds to consumers.
September 2019
February 2019
FDA Approves Esketamine for TRD
The treatment is in the form of a nasal spray containing ketamine.
June 2018
FDA Approves Epidiolex for Treating Some Epileptic Seizures
Epidiolex is the first FDA-approved drug containing cannabidiol (CBD).